Magnetic Resonance Spectroscopy in Ovarian Cancer Diagnostics

Magnetic resonance spectroscopy (MRS) offers a non-invasive means to probe the biochemical milieu of ovarian tissue, extending beyond the structural information provided by conventional imaging. By detecting the unique resonance frequencies of metabolites, MRS can characterise the concentrations of cellular components such as choline-containing compounds, lactate and lipids, which often change during malignant transformation. Advances in signal-processing algorithms, notably the fast Padé transform (FPT) and its derivative extension (dFPT), have markedly improved spectral resolution and quantification accuracy, enabling the separation of overlapping resonances and suppression of background noise. In vivo applications at clinical field strengths (3 T) and in vitro studies at ultra-high fields (14 T) have demonstrated consistent metabolic signatures distinguishing benign from malignant ovarian lesions. These developments hold promise for early detection, non-invasive grading and therapy monitoring, with potential to reduce unnecessary surgeries and personalise treatment. Ongoing efforts focus on standardising protocols, validating biomarker panels across institutions and integrating MRS into routine gynaecological oncology workflows.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Magnetic Resonance Spectroscopy in Ovarian Cancer Diagnostics publication trend

The graph below shows the total number of articles in magnetic resonance spectroscopy in ovarian cancer diagnostics across all publications each year (not limited to Nature Index journals).

Technical terms

Magnetic resonance spectroscopy (MRS): A technique that measures the chemical composition of tissues by detecting the magnetic resonance signals of nuclei, most commonly protons.

Fast Padé transform (FPT): A parametric signal-processing method that reconstructs spectral peaks by solving the harmonic inversion problem, offering improved resolution over Fourier analysis.

Derivative fast Padé transform (dFPT): An extension of the FPT that applies higher-order differentiation to narrow linewidths and suppress noise, enhancing the separation of overlapping resonances.

Chemical shift: The resonance frequency of a nucleus relative to a standard reference, expressed in parts per million (ppm), reflecting its molecular environment.

Choline compounds: Metabolites involved in membrane synthesis and cell proliferation, whose elevated concentrations often indicate tumour activity.

Lactate: A by-product of anaerobic glycolysis, frequently increased in malignant tissues due to altered energy metabolism.

References

1. Review of recent applications of the conventional and derivative fast Padé transform for magnetic resonance spectroscopy. Journal of Mathematical Chemistry (2019).
2. In vivo magnetic resonance spectroscopy for ovarian cancer diagnostics: quantification by the fast Padé transform. Journal of Mathematical Chemistry (2016).
3. Validation of reconstructed component spectra from non-parametric derivative envelopes: comparison with component lineshapes from parametric derivative estimations with the solved quantification problem. Journal of Mathematical Chemistry (2018).
4. In vitro proton magnetic resonance spectroscopy at 14T for benign and malignant ovary: Part I, signal processing by the nonparametric fast Padé transform. Journal of Mathematical Chemistry (2021).